In breast cancer, reducing intracellular O-GlcNAcation by inhibiting OGT attenuates the expression of the transcription factor FoxM1, further resulting in the downregulation of downstream target genes and inhibiting tumorigenesis (29). This evidence concerns the gene FOXM1 and breast cancer.